Stress Hormone-Related Psychopathology: Pathophysiological and Treatment Implications
The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
Stress is commonly associated with a variety of psychiatric conditions, including major depression, and with chronic medical conditions, including diabetes and insulin resistance. Whether stress causes these conditions is uncertain, but plausible mechanisms exist by which such effects might occur. To the extent stress-induced hormonal alterations (e.g., chronically elevated cortisol levels and lowered dehydroepiandrosterone [DHEA] levels) contribute to psychiatric and medical disease states, manipulations that normalize these hormonal aberrations should prove therapeutic. In this review, we discuss mechanisms by which hormonal imbalance (discussed in the frameworks of "allostatic load" and "anabolic balance") might contribute to illness. We then review certain clinical manifestations of such hormonal imbalances and discuss pharmacological and behavioural treatment strategies aimed at normalizing hormonal output and lessening psychiatric and physical pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541 · cited 4×
“In the brain, glucocorticoid inhibition of hippocampal glucose transport (which occurs at stress levels of glucocorticoids) (de Leon et al 1997) likely contributes to hippo- campal neuronal endangerment (Sapolsky et al 2000; Sapolsky et al 1990; Sapolsky 1993; Sapolsky 1994).”
BackgroundInfluentialSapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
Protective and Damaging Effects of Stress Mediators
McEwen, B. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801153380307 · Cited by 6,733 · cited 2×
“…without the protective effects of anabolic hormones, such as DHEA, can have extensive effects on physiological functioning, and, in particular, on aspects of metabolism (as can be seen in chronic stress, depression and Cushing’s syndrome) (McEwen 1998; McEwen and Stellar 1993; Seeman et al 1997).”
BackgroundChronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614 · cited 6×
“Additionally, recent evidence suggests that dexamethasone is actively excluded from brain and does not replace endogenous glucocorticoids at hippocampal MR and GR sites (De Kloet et al 1998).”
BackgroundInfluentialBrain corticosteroid receptor balance in health and disease
de Kloet, E. R. (1998) · Endocrine Reviews · doi:10.1210/er.19.3.269 · Cited by 2,614
The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis
SAPOLSKY, R. M., KREY, L. C., & McEWEN, B. S. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-3-284 · Cited by 2,298
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109
Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016
Allostasis and Allostatic Load Implications for Neuropsychopharmacology
McEwen, B. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00129-3 · Cited by 1,833
McEWEN, B. S., & SEEMAN, T. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08103.x · Cited by 1,824 · cited 2×
“Allostatic load is also thought to precede the expression of certain diagnosable chronic diseases (McEwen and Seeman 1999; Eriksen et al 1999).”
BackgroundAllostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging
Seeman, T. E., McEwen, B. S., Rowe, J. W., & Singer, B. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081072698 · Cited by 1,385 · cited 6×
“…load (Barbieri et al 2001; Christeff et al 2000; Epel et al 1998; Goodyer et al 1996; Hechter et al 1997; Herbert 1997; Herbert 1998; Matoulek et al 2000; McEwen 1998; McEwen and Seeman 1999; Wolkowitz and Reus 2000; Seeman et al 2001), contributing to depression and certain chronic diseases.”
BackgroundInfluentialSheline, Y. I., Sanghavi, M., Mintun, M. A., & Gado, M. H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05034.1999 · Cited by 1,382
Seeman, T. E. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440400111013 · Cited by 1,368
Hippocampal damage associated with prolonged glucocorticoid exposure in primates
Sapolsky, R., Uno, H., Rebert, C., & Finch, C. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-09-02897.1990 · Cited by 1,103
Effect of Neonatal Handling on Age-Related Impairments Associated with the Hippocampus
Meaney, M. J., Aitken, D. H., van Berkel, C., Bhatnagar, S., & Sapolsky, R. M. (1988) · Science · doi:10.1126/science.3340858 · Cited by 1,074 · cited 2×
“…al 1994; Weiss 1972), or experiencing "environmental enrichment" (e.g., increased physical activity, social stimulation and learning experiences) (Meaney et al 1988; Mohammed et al 1993; Kempermann et al 1997), yields neurochemical and behavioural benefits that are not even seen in unstressed…”
BackgroundEpel, E., Lapidus, R., McEwen, B., & Brownell, K. (2001) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(00)00035-4 · Cited by 1,060 · cited 2×
“…elevated, unopposed glucocorticoid activity is thus associated with indicators of metabolic dysregulation such as increased eating behaviour (Epel et al 2001b), changes in body composition such as increased visceral (central) adiposity and fat-to-lean mass ratio, peripheral muscle wasting,…”
BackgroundThe acute effects of corticosteroids on cognition: integration of animal and human model studies
LUPIEN, S., & MCEWEN, B. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00004-0 · Cited by 1,024 · cited 3×
“…the deleterious effects of glucocorticoid medication on memory in both patients and normal controls (Keenan et al 1996; Keenan et al 1995; Kirschbaum et al 1996; Lupien and McEwen 1997; Newcomer et al 1999; Varney et al 1984; Wolkowitz et al 1997a; Wolkowitz et al 1990a; Wolkowitz et al 1993c).”
BackgroundTrejo, J. L., Carro, E., & Torres-Alemán, I. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01628.2001 · Cited by 1,017 · cited 7×
“IGF-1, for example, increases hippocampal glucose utilization in aged animals (Lynch et al 2001) and increases adult hippocampal neurogenesis (Aberg et al 2000; Trejo et al 2001).”
BackgroundInfluentialAdult brain neurogenesis and psychiatry: a novel theory of depression
Jacobs, B. L., van Praag, H., & Gage, F. H. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000712 · Cited by 964
Peripheral Infusion of IGF-I Selectively Induces Neurogenesis in the Adult Rat Hippocampus
Åberg, M. A. I., Åberg, N. D., Hedbäcker, H., Oscarsson, J., & Eriksson, P. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-08-02896.2000 · Cited by 852
Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
Morales, A. J., Nolan, J. J., Nelson, J. C., & Yen, S. S. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.6.7515387 · Cited by 841 · cited 1×
“Beneficial mood and memory effects of DHEA treatment in normal individuals and in very mildly symptomatic populations have been demonstrated less consistently (Barnhart et al 1999; Diamond et al 1996; Huppert and Van Niekerk 2001; Morales et al 1994; Wolf et al 1997).”
BackgroundStarkman, M. N., Gebarski, S. S., Berent, S., & Schteingart, D. E. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90079-f · Cited by 840 · cited 2×
“Cushing’s syndrome patients also have diminished hippocampal formation volume (assessed radiographically) (Starkman et al 1992) that has been directly correlated with cognitive performance and inversely correlated with urinary free cortisol output (Starkman et al 1992).”
BackgroundSousa, N., Lukoyanov, N. V., Madeira, M. D., Almeida, O. F. X., & Paula-Barbosa, M. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00050-6 · Cited by 758 · cited 5×
“…concentrations are more likely to produce hippocampal neuronal damage under stressful than under non-stressful conditions (Sapolsky 2000a; Souza et al 2000), perhaps because chronic stress evokes other biochemical changes which have synergistic effects on neurotoxicity and…”
BackgroundInfluentialStress, Glucocorticoids, and Damage to the Nervous System: The Current State of Confusion
Sapolsky, R. M. (1996) · Stress · doi:10.3109/10253899609001092 · Cited by 738 · cited 1×
“Sapolsky (Sapolsky 1996) and McEwen (McEwen 2000b) have elaborated several mechanisms through which glucocorticoids can directly damage hippocampal neurons or increase their vulnerability to damage.”
BackgroundHippocampal damage associated with prolonged and fatal stress in primates
Uno, H., Tarara, R., Else, J., Suleman, M., & Sapolsky, R. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-05-01705.1989 · Cited by 728 · cited 1×
“However, chronically stressed vervet monkeys did show loss of hippocampal neurons, probably secondary to increased glucocorticoid exposure (Uno et al 1989).”
BackgroundRestoring production of hippocampal neurons in old age
Cameron, H. A., & McKay, R. D. G. (1999) · Nature Neuroscience · doi:10.1038/13197 · Cited by 710 · cited 1×
“Reducing glucocorticoid levels facilitates neurogenesis, even in aged animals, and results in increased numbers of hippocampal granule cells (Cameron and McKay 1999).”
BackgroundZobel, A. W., Nickel, T., Künzel, H. E., Ackl, N., Sonntag, A., Ising, M., & Holsboer, F. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(00)00016-9 · Cited by 705
The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death
Sapolsky, R. M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00971-9 · Cited by 699 · cited 5×
“…to elevated cortisol levels leads to decreased hippocampal volume (Bremner 1999; Herbert 1998; McEwen 2000c; O'Brien et al 1996; Sapolsky 2000a; Sapolsky 2000b; Sheline et al 1999; Starkman et al 1992) and to impaired hippocampus-dependent memory function (Lupien et al 1999; Starkman et al…”
BackgroundInfluentialRIZZA, R. A., MANDARINO, L. J., & GERICH, J. E. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-1-131 · Cited by 696
Piazza, P. V., & Le Moal, M. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.002043 · Cited by 690
Holsboer, F. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)90056-5 · Cited by 654 · cited 6×
“…and androsterone are promising neurosteroid targets for novel antidepressant or neuroprotective agent development (Barrot et al 1999; Frank and Sagratella 2000; George et al 1994; Maurice et al 1999; Meieran et al In Review; Patchev et al 1997; Rupprecht and Holsboer 1999a; Urbanoski et al 2000).”
BackgroundInfluentialDehydroepiandrosterone Replacement in Women with Adrenal Insufficiency
Arlt, W., Callies, F., van Vlijmen, J. C., Koehler, I., Reincke, M., Bidlingmaier, M., Huebler, D., Oettel, M., Ernst, M., Schulte, H. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411401 · Cited by 644
Effects of adverse experiences for brain structure and function
McEwen, B. S. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00964-1 · Cited by 639
Baulieu, E.-E., Thomas, G., Legrain, S., Lahlou, N., Roger, M., Debuire, B., Faucounau, V., Girard, L., Hervy, M.-P., Latour, F., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4279 · Cited by 577
Lustman, P. J., Griffith, L. S., Freedland, K. E., Kissel, S. S., & Clouse, R. E. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-8-199810150-00005 · Cited by 562
Decreased memory performance in healthy humans induced by stress-level cortisol treatment
Newcomer, J. W. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.6.527 · Cited by 546
Steroid-induced psychiatric syndromes
Lewis, D. A., & Smith, R. E. (1983) · Journal of Affective Disorders · doi:10.1016/0165-0327(83)90022-8 · Cited by 528 · cited 1×
“%) may experience a "steroid dementia syndrome," or longlasting memory impairment (again, hippocampal in nature) even after cessation of glucocorticoid medication (Lewis and Smith 1983; Reckart and Eisendrath 1990; Varney et al 1984; Wolkowitz et al 1997a).”
BackgroundBioavailable Testosterone and Depressed Mood in Older Men: The Rancho Bernardo Study
Barrett-Connor, E., von Mühlen, D. G., & Kritz-Silverstein, D. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5495 · Cited by 472 · cited 1×
“Indeed, recent epidemiological and cross-sectional studies have demonstrated positive correlations between serum levels of bioavailable testosterone and ratings of mood and cognitive function in men (Barrett-Connor et al 1999; Morley et al 1997).”
BackgroundBody fat distribution, insulin resistance, and metabolic diseases
Björntorp, P. (1997) · Nutrition · doi:10.1016/s0899-9007(97)00191-3 · Cited by 470
Psychological stress, drug-related cues and cocaine craving
Sinha, R., Fuse, T., Aubin, L.-R., & O'Malley, S. S. (2000) · Psychopharmacology · doi:10.1007/s002130000499 · Cited by 463
Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing’s disease
Starkman, M. N., Giordani, B., Gebarski, S. S., Berent, S., Schork, M. A., & Schteingart, D. E. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00203-6 · Cited by 455
Kimonides, V. G., Khatibi, N. H., Svendsen, C. N., Sofroniew, M. V., & Herbert, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1852 · Cited by 438 · cited 2×
“…certain of the deleterious effects of chronic cortisol or corticosterone exposure and, in addition, protects hippocampal tissue (Bastianetto et al 1999; Cardounel et al 1999; Kimonides et al 1998; Kimonides et al 1999; Mao and Barger 1998) and enhances hippocampal function (Murialdo et al 2000).”
BackgroundMorales, A. J., Haubrich, R. H., Hwang, J. Y., Asakura, H., & Yen, S. S. C. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00507.x · Cited by 418
NESTLER, J. E., BARLASCINI, C. O., CLORE, J. N., & BLACKARD, W. G. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-57 · Cited by 414
Double-blind treatment of major depression with dehydroepiandrosterone.
Wolkowitz, O. M., Reus, V. I., Keebler, A., Nelson, N., Friedland, M., Brizendine, L., & Roberts, E. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.4.646 · Cited by 411 · cited 3×
“These researchers subsequently reported on a sample of depressed patients treated with ketoconazole in a double-blind, placebo-controlled trial (Wolkowitz et al 1999a).”
BackgroundSelective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes
Griffin, L. D., & Mellon, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13512 · Cited by 387
Hunt, P. J., Gurnell, E. M., Huppert, F. A., Richards, C., Prevost, A. T., Wass, J. A. H., Herbert, J., & Chatterjee, V. K. K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7022 · Cited by 386 · cited 1×
“…1997b) and dysthymia (Bloch et al 1999), mildly and transiently improves cognitive performance in patients with Alzheimer’s disease (Wolkowitz et al 2000b) and enhances well-being, energy and libido in hypo-adrenal patients with Addison’s disease (Arlt et al 1999; Arlt et al 1998; Hunt et al 2000).”
BackgroundAllostasis, amygdala, and anticipatory angst
Schulkin, J., McEwen, B. S., & Gold, P. W. (1994) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)90051-5 · Cited by 380 · cited 1×
“…of CRH hypersecretion in symptoms such as anxiety, fear, over-arousal, decreased slow wave sleep, decreased eating and decreased libido (Gold and Chrousos 1985; Gold and Chrousos 1999; Holsboer 1988; Holsboer 1999; Holsboer 2000; Kling et al 1991; O'Brien et al 2001; Schulkin et al 1994).”
BackgroundROSENBERG, D. R., MacMASTER, F. P., KESHAVAN, M. S., FITZGERALD, K. D., STEWART, C. M., & MOORE, G. J. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200009000-00008 · Cited by 377
Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders
McEwen, B. S., & Magarinos, A. M. (2001) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.266 · Cited by 349 · cited 3×
“McEwen BS, Magarinos AM (2001) Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders.”
BackgroundInfluentialRusso-Neustadt, A., Ha, T., Ramirez, R., & Kesslak, J. P. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00364-8 · Cited by 346 · cited 1×
“…interventions that lower cortisol levels, such as those discussed here, are capable of increasing BDNF levels, but in animals, physical exercise blocks stress-induced decreases in brain BDNF mRNA levels (Russo-Neustadt et al 2001) and increases adult hippocampal neurogenesis (Trejo et al 2001).”
BackgroundAnti-glucocorticoid effects of dehydroepiandrosterone (DHEA).
Kalimi, M., Shafagoj, Y., Loria, R., Padgett, D., & Regelson, W. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf00925945 · Cited by 328
Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice.
Coleman, D. L., Leiter, E. H., & Schwizer, R. W. (1982) · Diabetes · doi:10.2337/diab.31.9.830 · Cited by 317 · cited 1×
“…peripheral catabolic effects of glucocorticoids by increasing sensitivity to insulin, enhancing adipocyte glucose uptake and diminishing hyperglycemia (Coleman et al 1982) and reducing adiposity (DongHo et al 1998), but similar effects have not been uniformly found in humans (Wellman et al 1999).”
BackgroundVerhelst, J. A., Trainer, P. J., Howlett, T. A., Perry, L., Rees, L. H., Grossman, A. B., Wass, J. A. H., & Sesser, G. M. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03517.x · Cited by 308 · cited 2×
“The largest two case series documented a response rate of 70-73% of treated patients (Sonino et al 1993; Verhelst et al 1991), although, in several cases, psychiatric improvement was erratic, delayed or incomplete (Haskett 1985; Hamm 1955; Ernest and Ekman 1972).”
BackgroundLabrie, F., Diamond, P., Cusan, L., Gomez, J.-L., Bélanger, A., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4306 · Cited by 292
Starkman, M. N., Schteingart, D. E., & Schork, A. M. (1981) · Psychosomatic Medicine · doi:10.1097/00006842-198102000-00002 · Cited by 289
Subclinical Cushing’s syndrome
Reincke, M. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70115-8 · Cited by 285 · cited 1×
“In studies examining symptoms of such adrenal masses, participants who met criteria for subtle hypercortisolemia showed signs of hypertension, impaired glucose tolerance or diabetes, hyperlipidemia and obesity (Rossi et al 2000; Reincke 2000).”
BackgroundLupien, S. J., Nair, N. P. V., Briére, S., Maheu, F., Tu, M. T., Lemay, Μ., McEwen, B. S., & Meaney, M. J. (1999) · Reviews in the Neurosciences · doi:10.1515/revneuro.1999.10.2.117 · Cited by 283
Effects of Stress Reduction on Carotid Atherosclerosis in Hypertensive African Americans
Castillo-Richmond, A., Schneider, R. H., Alexander, C. N., Cook, R., Myers, H., Nidich, S., Haney, C., Rainforth, M., & Salerno, J. (2000) · Stroke · doi:10.1161/01.str.31.3.568 · Cited by 262
Ketoconazole treatment in Cushing’s syndrome: experience in 34 patients
Sonino, N., Boscaro, M., Paoletta, A., Mantero, F., & Zillotto, D. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03547.x · Cited by 201 · cited 2×
“Antiglucocorticoid medication normalizes blood pressure, blood sugar control, hypokalemia, hirsutism and menstrual disturbances in the majority of Cushing’s syndrome patients (Sonino et al 1991).”
BackgroundArlt, W., Justl, H.-G., Callies, F., Reincke, M., Hübler, D., Oettel, M., Ernst, M., Schulte, H. M., & Allolio, B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4850 · Cited by 199
Sudsuang, R., Chentanez, V., & Veluvan, K. (1991) · Physiology & Behavior · doi:10.1016/0031-9384(91)90543-w · Cited by 198 · cited 1×
“Experimental groups that learned to regularly meditate suppressed cortisol compared to controls (Gallois et al 1984; Jevning et al 1978; Sudsuang et al 1991); however, see Michaels et al (1979).”
MethodReversible steroid dementia in patients without steroid psychosis
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.3.369 · Cited by 194 · cited 2×
“…the deleterious effects of glucocorticoid medication on memory in both patients and normal controls (Keenan et al 1996; Keenan et al 1995; Kirschbaum et al 1996; Lupien and McEwen 1997; Newcomer et al 1999; Varney et al 1984; Wolkowitz et al 1997a; Wolkowitz et al 1990a; Wolkowitz et al 1993c).”
BackgroundDehydroepiandrosterone treatment of midlife dysthymia∗∗See accompanying Editorial, in this issue.
Bloch, M., Schmidt, P. J., Danaceau, M. A., Adams, L. F., & Rubinow, D. R. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00066-9 · Cited by 179 · cited 1×
“…has antidepressant effects in patients with major depression (Wolkowitz et al 1995; Wolkowitz et al 1999b; Wolkowitz et al 1997b) and dysthymia (Bloch et al 1999), mildly and transiently improves cognitive performance in patients with Alzheimer’s disease (Wolkowitz et al 2000b) and enhances…”
BackgroundWalton, K. G., Pugh, N. D. C., Gelderloos, P., & Macrae, P. (1995) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.1995.1.263 · Cited by 163
Leverenz, J. B., Wilkinson, C. W., Wamble, M., Corbin, S., Grabber, J. E., Raskind, M. A., & Peskind, E. R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-06-02356.1999 · Cited by 154 · cited 1×
“In a prospective study in Macaques examining hippocampal cell number at autopsy, administration of 3-6 mg/kg/day of hydrocortisone for 12 months could not be distinguished from placebo (Leverenz et al 1999).”
BackgroundAn experimental study of social isolation of elderly people: Psychoendocrine and metabolic effects
Arnetz, B. B., Theorell, T., Levi, L., Kallner, A., & Eneroth, P. (1983) · Psychosomatic Medicine · doi:10.1097/00006842-198310000-00003 · Cited by 140
Möckel, M., Röcker, L., Störk, T., Vollert, J., Danne, O., Eichstädt, H., Müller, R., & Hochrein, H. (1994) · European Journal of Applied Physiology and Occupational Physiology · doi:10.1007/bf00599512 · Cited by 137
Testosterone and Regional Fat Distribution
Mårin, P. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00233.x · Cited by 129 · cited 1×
“…hormone in both genders, especially for those who are growth hormone deficient, can reverse metabolic defects such as visceral and total adiposity (Marin 1995; Thompson et al 1998) and decrease insulin resistance (Berneis and Keller 1996) and, in many cases, depressive symptoms (Thompson et al…”
BackgroundAbnormal Results of Dexamethasone Suppression Tests in Nondepressed Patients With Diabetes Mellitus
Hudson, J. I. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790220076012 · Cited by 91 · cited 1×
“In fact, even in nondepressed diabetics, there is higher DST non-suppression (43% nonsupressors) compared to normal controls (Hudson et al 1984).”
BackgroundDehydroepiandrosterone: antiglucocorticoid action in mice.
Browne, E. S., Wright, B. E., Porter, J. R., & Svec, F. (1992) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199206000-00003 · Cited by 77 · cited 2×
“Indeed, multiple studies have verified DHEA’s ability, both in vitro and in vivo, to antagonize certain of cortisol’s physiological effects (Browne et al 1992; Hechter et al 1997; Kalimi et al 1994; Patchev and Almeida 1997; Svec and Porter 1998) and to prevent certain physiological sequellae of…”
BackgroundTreatment of major depression with steroid suppressive drugs
Pearson Murphy, B. E. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90069-h · Cited by 67
Cited by
Maninger, N., Wolkowitz, O. M., Reus, V. I., Epel, E. S., & Mellon, S. H. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.11.002 · Cited by 769
Self-citationPatel, S., Roelke, C. T., Rademacher, D. J., Cullinan, W. E., & Hillard, C. J. (2004) · Endocrinology · doi:10.1210/en.2004-0638 · Cited by 475
Effects of hatha yoga and african dance on perceived stress, affect, and salivary cortisol
West, J., Otte, C., Geher, K., Johnson, J., & Mohr, D. C. (2004) · Annals of Behavioral Medicine · doi:10.1207/s15324796abm2802_6 · Cited by 420
A meta-analysis of cortisol response to challenge in human aging: importance of gender
Otte, C., Hart, S., Neylan, T. C., Marmar, C. R., Yaffe, K., & Mohr, D. C. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.06.002 · Cited by 414
Shea, A., Walsh, C., MacMillan, H., & Steiner, M. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.07.001 · Cited by 378
Metadata
- Authors
- Wolkowitz, O. M., Epel, E. S., & Reus, V. I.
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2001-01
- Volume
- 2
- Issue
- 3
- Pages
- 115-143
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2095182636
- Cited by
- 151
- References
- 74
- FWCI
- 1.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.